Inhibition of clonogenic tumor growth: A novel function of Smac contributing to its antitumor activity

Oncogene

Volumn 24, Issue 48, 2005, Pages 7190-7202

  Vogler, Meike ^a   Giagkousiklidis, Stavros ^a   Genze, Felicitas ^a   Gschwend, Juergen E ^a   Debatin, Klaus Michael ^a   Fulda, Simone ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; Cancer; IAP; Smac

Indexed keywords

FLICE INHIBITORY PROTEIN; MESSENGER RNA; PROTEIN P21; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CELL DENSITY; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CLONOGENESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; MINIMAL RESIDUAL DISEASE; MITOSIS INHIBITION; NEUROBLASTOMA CELL; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SENESCENCE; TUMOR GROWTH;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CARCINOMA; CASPASES; CELL COUNT; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYTOSOL; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEUROBLASTOMA; PANCREATIC NEOPLASMS; PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 27944506044     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208876     Document Type: Article

References (37)

1. Altieri DC. (2003). Nat. Rev. Cancer, 3, 46-54.
2. Ashkenazi A. (2002). Nat. Rev. Cancer, 2, 420-430.
3. Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y. (2000). Nature, 406, 855-862.
4. Creagh EM, Murphy BM, Duriez PJ, Duckett CS and Martin SJ. (2004). J. Biol. Chem., 279, 26906-26914.
5. Degterev A, Boyce M and Yuan J. (2003). Oncogene, 22, 8543-8567.
6. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M and Campisi J. (1995). PNAS, 92, 9363-9367.
7. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME and Debatin KM. (1997). Cancer Res., 57, 4956-4964.
8. Fulda S, Wick W, Weller M and Debatin KM. (2002). Nat. Med., 8, 808-815.
9. Geisbrecht ER and Montell DJ. (2004). Cell, 118, 111-125.
10. Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C, Wang HG and Bhalla K. (2002). Blood, 99, 3419-3426.
11. Hao Y, Sekine K, Kawabata A, Nakamura H, Ishioka T, Ohata H, Katayama R, Hashimoto C, Zhang X, Noda T, Tsuruo T and Naito M. (2004). Nat. Cell Biol., 6, 849-860.
12. Hasenjager A, Gillissen B, Muller A, Normand G, Hemmati PG, Schuler M, Dorken B and Daniel PT. (2004). Oncogene, 23, 4523-4535.
13. Hengartner MO. (2000). Nature, 407, 770-776.
14. Holley CL, Olson MR, Colon-Ramos DA and Kornbluth S. (2002). Nat. Cell Biol., 4, 439-444.
15. Hu S and Yang X. (2003). J. Biol. Chem., 278, 10055-10060.
16. Jia L, Patwari Y, Kelsey SM, Srinivasula SM, Agrawal SG, Alnemri ES and Newland AC. (2003). Oncogene, 22, 1589-1599.
17. Kuefer R, Hofer MD, Altug V, Zorn C, Genze F, Kunzi-Rapp K, Hautmann RE and Gschwend JE. (2004). Br. J. Cancer, 90, 535-541.
18. MacFarlane M, Merrison W, Bratton SB and Cohen GM. (2002). J. Biol. Chem., 277, 36611-36616.
19. McNeish IA, Bell S, McKay T, Tenev T, Marani M and Lemoine NR. (2003). Exp. Cell Res., 286, 186-198.
20. McNeish IA, Lopes R, Bell SJ, McKay TR, Fernandez M, Lockley M, Wheatley SP and Lemoine NR. (2005). Exp. Cell Res., 302, 69-82.
21. Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B and Miki T. (2005). J. Clin. Oncol., 23, 448-454.
22. Ng CP and Bonavida B. (2002). Mol. Cancer Ther., 1, 1051-1058.
23. Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R, Gu J, Qian C and Liu X. (2004). Hepatology, 39, 1371-1381.
24. Roberts DL, Merrison W, MacFarlane M and Cohen GM. (2001). J. Cell Biol., 153, 221-228.
25. Robertson JD, Gogvadze V, Kropotov A, Vakifahmetoglu H, Zhivotovsky B and Orrenius S. (2004). EMBO Rep., 5, 643-648.
26. Saelens X, Festjens N, Walle LV, van Gurp M, van Loo G and Vandenabeele P. (2004). Oncogene, 23, 2861-2874.
27. Salvesen GS and Duckett CS. (2002). Nat. Rev. Mol. Cell. Biol., 3, 401-410.
28. Scaffidi C, Medema JP, Krammer PH and Peter ME. (1997). J. Biol. Chem., 272, 26953-26958.
29. Shiozaki EN and Shi Y. (2004). Trends Biochem. Sci., 29, 486-494.
30. Silke J, Kratina T, Ekert PG, Pakusch M and Vaux DL. (2004). J. Biol. Chem., 279, 4313-4321.
31. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z and Alnemri ES. (2000). J. Biol. Chem., 275, 36152-36157.
32. Vaux DL and Silke J. (2003). Biochem. Biophys. Res. Comm., 304, 499-504.
33. Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X and Shi Y. (2000). Nature, 408, 1008-1012.
34. Yan Y, Mahotka C, Heikaus S, Shibata T, Wethkamp N, Liebmann J, Suschek CV, Guo Y, Gabbert HE, Gerharz CD and Ramp U. (2004). Br. J. Cancer, 91, 1349-1357.
35. Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-hara T and Tsuruo T. (2003). Cancer Res., 63, 831-837.
36. Yang QH and Du C. (2004). J. Biol. Chem., 279, 16963-16970.
37. Yoo SJ, Huh JR, Muro I, Yu H, Wang L, Wang SL, Feldman RM, Clem RJ, Muller HA and Hay BA. (2002). Nat. Cell Biol., 4, 416-424.